TERN

Terns Pharmaceuticals Inc

May 04 • 04:00PM ET

52.95

0.00 0.00 %

Healthcare • Biotechnology • USA • Mid • NASD

| Held by: VTI VXF VTWO VHT VTWV VTHR BTEC

Index	-	P/E	-	EPS (ttm)	-1.03	Insider Own	8.72%	Shs Outstand	112.32M	Perf Week	-
Market Cap	6.12B	Forward P/E	-	EPS next Y	-1.69	Insider Trans	-1.67%	Shs Float	105.45M	Perf Month	0.49%
Enterprise Value	5.10B	PEG	-	EPS next Q	-0.28	Inst Own	102.93%	Short Float	5.25%	Perf Quarter	40.12%
Income	-96.21M	P/S	-	EPS this Y	-20.18%	Inst Trans	-	Short Ratio	0.96	Perf Half Y	160.84%
Sales	0.00M	P/B	5.91	EPS next Y	-29.01%	ROA	-13.85%	Short Interest	5.54M	Perf YTD	31.06%
Book/sh	8.96	P/C	6.00	EPS next 5Y	-22.36%	ROE	-14.23%	52W High	53.19 -0.45%	Perf Year	1412.86%
Cash/sh	8.82	P/FCF	-	EPS past 3/5Y	14.89% 2.44%	ROIC	-9.55%	52W Low	2.65 1894.35%	Perf 3Y	321.24%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	0.07% 0.18%	Perf 5Y	185.91%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	8.38%	Oper. Margin	-	ATR (14)	0.43	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	62.41	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	73.93	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	62.41	EPS Q/Q	-0.25%	SMA20	0.32%	Beta	-0.41	Target Price	53.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	7.60%	Rel Volume	0.00	Prev Close	52.95
Employees	59	LT Debt/Eq	0.00	Earnings	Mar 31	SMA200	90.80%	Avg Volume	5.79M	Price	52.95
IPO	Feb 05, 2021	Option/Short	Yes / No	EPS/Sales Surpr.	-4.24% -	Trades		Volume	0	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-25-26	Downgrade	H.C. Wainwright	Buy → Neutral
Feb-09-26	Initiated	Leerink Partners	Outperform	$58
Nov-04-25	Upgrade	H.C. Wainwright	Neutral → Buy	$20
Nov-03-25	Upgrade	William Blair	Mkt Perform → Outperform
Oct-15-25	Initiated	Truist	Buy	$20
Sep-17-25	Initiated	Barclays	Overweight	$15
Sep-04-25	Resumed	H.C. Wainwright	Neutral
Feb-28-25	Initiated	William Blair	Mkt Perform
Oct-31-24	Initiated	Oppenheimer	Outperform	$82
Jun-22-23	Initiated	Mizuho	Buy	$16
Jun-07-23	Initiated	Jefferies	Buy	$18
May-31-23	Initiated	ROTH MKM	Buy	$23
May-08-23	Initiated	BMO Capital Markets	Outperform	$18
Feb-14-23	Initiated	JMP Securities	Mkt Outperform	$17
Feb-07-23	Initiated	UBS	Buy	$19
Sep-12-22	Initiated	H.C. Wainwright	Neutral	$6
Sep-14-21	Resumed	Goldman	Buy	$21
Mar-02-21	Initiated	JP Morgan	Overweight	$32
Mar-02-21	Initiated	Goldman	Buy	$29
Mar-02-21	Initiated	Cowen	Outperform

Show Previous Ratings

May-06-26 05:47AM	MSD concludes Terns acquisition to expand CML pipeline (Hospital Management)
May-05-26 08:45AM	Merck Completes Acquisition of Terns Pharmaceuticals, Inc. (Business Wire)
Apr-30-26 08:21AM	Merck still sees compelling outlook for Terns leukemia drug (BioPharma Dive)
Apr-27-26 08:05AM	Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia (GlobeNewswire)
Apr-24-26 06:45AM	Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc. (Business Wire)
07:59AM	Loading…
Apr-15-26 07:59AM	Are TERN, SLNO, WSR Obtaining Fair Deals for their Shareholders? (PR Newswire)
Apr-09-26 03:29PM	Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? (PR Newswire)
Apr-07-26 09:00AM	Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc. (Business Wire)
08:28AM	Terns rebuffed a higher bid before selling to Merck (BioPharma Dive)
Apr-02-26 04:05PM	Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire)
Mar-31-26 09:32AM	Western Digital upgraded, PayPal initiated: Wall Street's top analyst calls (The Fly)
Mar-30-26 11:09AM	Mercks strategic shift: acquires Terns for $6.7bn, targeting dominance in CML (Pharmaceutical Technology)
09:41AM	Netflix initiated, Instacart upgraded: Wall Street's top analyst calls (The Fly)
Mar-27-26 09:46AM	Wix downgraded, TripAdvisor upgraded: Wall Street's top analyst calls (The Fly)
Mar-26-26 10:50AM	Are TERN, CRBG, EQH Obtaining Fair Deals for their Shareholders? (PR Newswire)
08:10AM	Loading…
08:10AM	Mercks deal for Terns sparks debate over a possible biotech bidding war (BioPharma Dive)
12:01AM	Merck Preps for End of Keytruda Exclusivity with $6.7B Deal for Leukemia Treatment (The Daily Upside)
Mar-25-26 11:49AM	MSD spends $6.7bn to buy Terns Pharmaceuticals in cancer pipeline reinforcement (Pharmaceutical Technology) +5.72%
11:23AM	Nasdaq bounces as oil price softens as US pushes for Iran talks (Proactive)
10:41AM	Merck to acquire Terns Pharmaceuticals for $6.7B (Proactive)
09:39AM	Merck buying Terns in $6.7B deal to bolster its cancer portfolio before key Keytruda patent expires (Associated Press Finance)
07:35AM	Merck makes a big move into new cancer treatments with a $6.7 billion buyout deal (MarketWatch)
07:21AM	Merck to buy oncology firm Terns Pharmaceuticals in $6.7 billion deal (Investing.com)
06:49AM	Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns (The Wall Street Journal)
06:45AM	Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) (Business Wire)
04:50AM	Merck to buy Terns in $6.7B bet on a differentiated leukemia drug (BioPharma Dive)
Feb-27-26 04:04PM	Analyst Optimistic on Terns (TERN) Citing Possible $4.8B Market for Upcoming Leukemia Drug (Insider Monkey)
Feb-25-26 04:05PM	Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences (GlobeNewswire)
Feb-23-26 09:06AM	Viatris Stock to Report Q4 Earnings: What's in the Cards? (Zacks)
Feb-04-26 09:55AM	Wall Street Analysts See a 50.91% Upside in Terns Pharmaceuticals (TERN): Can the Stock Really Move This High? (Zacks) -6.39%
04:05PM	Loading…
Feb-02-26 04:05PM	Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire) +6.42%
04:16AM	Terns Pharmaceuticals (TERN) Eyes Expansion Beyond China Amid Strong Analyst Sentiment (Insider Monkey)
Jan-23-26 05:27AM	Novo climbs higher on strong Wegovy pill launch; Terns tweaks leukemia drug deal (BioPharma Dive)
Jan-15-26 11:35AM	Wall Street Forecasts 42.31% Upside To Terns Pharmaceuticals, Inc. (TERN) (Insider Monkey)
Jan-11-26 01:00AM	Citizens Maintains An Outperform Rating On Terns Pharmaceuticals, Inc. (TERN) (Insider Monkey)
Jan-07-26 04:05PM	Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -5.57%
Jan-02-26 04:05PM	Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire)
Dec-19-25 03:14PM	Jim Cramer Highlights Massive Gains for Terns Pharmaceuticals Shareholders (Insider Monkey)
Dec-15-25 06:47PM	Terns CEO Amy Burroughs talks cancer drug trial win (CNBC TV)
Dec-14-25 02:40PM	Terns Pharmaceuticals (TERN) Climbs 53% on Stellar Leukemia Treatment Trial (Insider Monkey)
Dec-11-25 04:05PM	Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire) +5.56%
Dec-09-25 11:30PM	Terns Announces Pricing of Upsized $650 Million Public Offering (GlobeNewswire) +5.82%
03:31PM	Cancer Study Buoys These Small Biotechs (Barrons.com)
02:23PM	Terns (TERN) Hits All-Time High on Stellar Leukemia Treatment Results (Insider Monkey)
06:12AM	Terns Announces Proposed Public Offering (GlobeNewswire)
Dec-08-25 02:45PM	Terns Highlights Additional Positive Phase 1 Clinical Data Supporting TERN-701's Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting (GlobeNewswire) +37.02%
Dec-04-25 07:57AM	These stocks are new additions to Mizuhos Americas Top Picks list (Investing.com)
Nov-23-25 07:02AM	BMO Believes Market Undervalues Terns Pharmaceuticals (TERN) Despite Strong Trial Data (Insider Monkey)
Nov-18-25 12:43AM	Terns Pharmaceuticals (TERN) Soars to New Record High of $26.12 (Insider Monkey) +7.82%
Nov-17-25 12:15PM	William Blair Reiterates a Buy on Terns Pharmaceuticals (TERN) (Insider Monkey) +13.30%
Nov-14-25 04:05PM	Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London (GlobeNewswire) +8.83%
Nov-10-25 04:05PM	Terns Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Updates (GlobeNewswire) +7.64%
Nov-04-25 04:05PM	Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire) +24.23%
Nov-03-25 09:05AM	Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting (GlobeNewswire) +69.85%
Oct-24-25 04:58AM	Chugai buys a kidney biotech; ICER targets rising launch prices (BioPharma Dive)
Oct-21-25 04:05PM	Terns Pharmaceuticals Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist TERN-601 in Obesity (GlobeNewswire) -5.80%
Oct-02-25 04:05PM	Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire)
Sep-21-25 10:45AM	2 Under-the-Radar Stocks That Could Soar (Motley Fool)
Aug-21-25 04:05PM	Terns Pharmaceuticals to Host an Educational Webinar on TERN-701 for Investors in Advance of Phase 1 Data Expected in Fourth Quarter 2025 (GlobeNewswire) +7.30%
Aug-07-25 09:55AM	Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors (Benzinga)
Aug-05-25 04:05PM	Terns Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Updates (GlobeNewswire) +5.74% -6.74%
Aug-04-25 04:05PM	Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire) +5.12%
Jun-23-25 04:07PM	Terns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American Diabetes Association Scientific Sessions (GlobeNewswire) -5.64%
May-29-25 04:05PM	Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences (GlobeNewswire)
May-14-25 09:30AM	Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701 (GlobeNewswire)
May-09-25 07:54AM	Is Terns Pharmaceuticals, Inc. (TERN) the Low Risk High Reward Stock Set to Triple by 2030? (Insider Monkey)
May-08-25 04:05PM	Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates (GlobeNewswire)
May-02-25 04:05PM	Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire) -5.71%
Apr-30-25 04:05PM	Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference (GlobeNewswire) +6.11% +7.88%
Apr-26-25 08:50AM	Novo Nordisk: Examining Tariff And Pricing Risks (Seeking Alpha)
Apr-07-25 09:35AM	Down -39.83% in 4 Weeks, Here's Why Terns Pharmaceuticals (TERN) Looks Ripe for a Turnaround (Zacks)
Apr-03-25 09:35AM	Down -31.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Terns Pharmaceuticals (TERN) (Zacks) -6.43%
Apr-02-25 04:05PM	Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire)
Mar-26-25 12:00PM	All You Need to Know About Terns Pharmaceuticals (TERN) Rating Upgrade to Buy (Zacks) -6.63%
Mar-20-25 04:05PM	Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates (GlobeNewswire) +6.69%
Mar-09-25 10:03AM	This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street (Motley Fool)
Feb-26-25 04:05PM	Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire)
Feb-25-25 08:05AM	Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference (GlobeNewswire)
03:00AM	Its CEO died. The company scrapped a promising program. Now, for their 2nd act. (Pharma Voice)
Feb-24-25 04:05PM	Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer (GlobeNewswire) -6.87%
Feb-20-25 04:05PM	Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors (GlobeNewswire)
Feb-05-25 04:05PM	Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Feb-03-25 04:05PM	Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire)
Jan-08-25 04:05PM	Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -6.84%
Jan-02-25 04:05PM	Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire)
Dec-16-24 01:10PM	Is Terns Pharmaceuticals, Inc. (TERN) the Best Weight Loss Stock to Buy Now According to Hedge Funds? (Insider Monkey)
Dec-03-24 07:00AM	Terns Pharmaceuticals Announces Positive Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid Leukemia (GlobeNewswire)
Dec-02-24 04:05PM	Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire)
Nov-18-24 04:05PM	Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors (GlobeNewswire) -7.62%
Nov-12-24 04:05PM	Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates (GlobeNewswire) -5.44%
Nov-06-24 04:05PM	Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences (GlobeNewswire)
Oct-07-24 04:05PM	Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire) -5.08%
Sep-24-24 03:22AM	Insiders Snap Up These 2 Strong Buy Stocks (TipRanks)
Sep-18-24 10:07AM	This Small-Cap Stock Has a Promising GLP-1 Drug That Could Rival Novo Nordisk's and Eli Lilly's Weight Loss Treatments (Motley Fool) +6.02%
Sep-17-24 01:30AM	OrbiMed Advisors LLC Increases Stake in Terns Pharmaceuticals Inc (GuruFocus.com)
Sep-15-24 07:21AM	Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now. (Motley Fool)
06:09AM	Should You Invest in This Under-the-Radar Weight Loss Stock? (Motley Fool)
Sep-14-24 10:12AM	1 New Weight Loss Drug Stock to Buy Now With $1,000 and Hold for 5 Years or More (Motley Fool)
Sep-12-24 07:00PM	Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire) -10.96% -5.84%
Sep-10-24 10:50PM	Terns Announces Pricing of Upsized $150.15 Million Public Offering (GlobeNewswire) +23.14%

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.

CEO & DirectorMs. Amy L. Burroughs M.B.A.

Chief Development & Operations OfficerMr. Scott Harris

Chief Legal OfficerMs. Caryn Gordon McDowell J.D.

Vice President of MarketingMs. Theresa Clouser

Chief People OfficerMs. Robin Andrulevich

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kuriakose Emil	Chief Medical Officer	Apr 01 '26	Sale	52.75	942	49,693	105,673	Apr 02 06:15 PM
Burroughs Amy L.	Chief Executive Officer	Mar 16 '26	Option Exercise	4.64	14,583	67,665	303,559	Mar 17 06:10 PM
Burroughs Amy L.	Chief Executive Officer	Mar 16 '26	Sale	46.71	14,583	681,108	288,976	Mar 17 06:10 PM
Burroughs Amy L.	Chief Executive Officer	Feb 17 '26	Option Exercise	4.64	14,583	67,665	303,559	Feb 18 07:01 PM
Burroughs Amy L.	Chief Executive Officer	Feb 17 '26	Sale	39.19	14,583	571,579	288,976	Feb 18 07:01 PM
Burroughs Amy L.	Chief Executive Officer	Jan 15 '26	Option Exercise	4.64	68,749	318,995	357,725	Jan 16 05:22 PM
Burroughs Amy L.	Chief Executive Officer	Jan 15 '26	Sale	37.07	68,749	2,548,603	288,976	Jan 16 05:22 PM
AMY BURROUGHS	Director	Jan 15 '26	Proposed Sale	37.18	97,915	3,640,480		Jan 15 04:24 PM
Burroughs Amy L.	Chief Executive Officer	Jan 02 '26	Option Exercise	4.64	21,551	99,997	60,315	Jan 06 08:26 PM
Burroughs Amy L.	Chief Executive Officer	Jan 05 '26	Sale	38.10	71,339	2,718,230	138,976	Jan 06 08:26 PM
Kuriakose Emil	Chief Medical Officer	Jan 02 '26	Sale	38.57	1,155	44,552	50,365	Jan 06 08:25 PM
Quigley Jill M.	Director	Nov 04 '25	Option Exercise	9.24	24,520	226,565	24,520	Nov 05 06:17 PM
Quigley Jill M.	Director	Nov 04 '25	Sale	18.00	24,520	441,360	0	Nov 05 06:17 PM
JILL QUIGLEY	Director	Nov 04 '25	Proposed Sale	14.03	24,520	344,016		Nov 04 04:32 PM
Kuriakose Emil	Chief Medical Officer	Oct 01 '25	Sale	7.85	944	7,407	51,520	Oct 02 07:24 PM
Kuriakose Emil	Chief Medical Officer	Jul 01 '25	Sale	4.27	853	3,640	52,464	Jul 03 02:55 PM
Gengos Andrew	Chief Financial Officer	Jun 27 '25	Buy	3.93	10,000	39,283	25,000	Jun 30 05:38 PM
Burroughs Amy L.	Chief Executive Officer	Jun 25 '25	Buy	3.87	23,314	90,230	47,083	Jun 25 06:08 PM
Gengos Andrew	Chief Financial Officer	Jun 13 '25	Buy	3.73	10,000	37,350	10,000	Jun 16 06:05 PM
Gengos Andrew	Chief Financial Officer	Jun 16 '25	Buy	3.95	5,000	19,732	15,000	Jun 16 06:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TERN

Terns Pharmaceuticals Inc

Upgrade your Finviz experience